NEWS COMMENTARY

Newly identified digital biomarker helps identify likelihood of positive response to antidepressant

Published:
February 11, 2020
Coverage:
Digital Transformation More...
Activities:
Research
Very important

By using a machine learning algorithm to assess EEG data, researchers have identified patterns that predict a patient's response to a specific antidepressant (sertraline). The use of digital biomarkers, such as EEG patterns, for diagnostics and personalized treatment is a growing trend as data analytics uncover previously invisible insights. In the U.S., while biomarkers in and of themselves are not patentable, as part of a diagnostic leading to a specific treatment, there is potential patentability. The discovery of data analytics-based digital biomarkers is more accessible to nontraditional healthcare players – unlocking opportunities for clients to develop proprietary healthcare diagnostics revenue streams.

For the original news article, click here .


Further Reading

Yitu claims its AI-based CT image analysis system can identify COVID-19 in three seconds at a high accuracy

News Commentary | April 28, 2020

The system is the result of Yitu's partnership with the Shanghai Public Health Clinical Center with a target of easing the doctors' burden by identifying COVID‑19 cases via automatic detection and quantitative analysis. This system has false negative and false positive rates of 2.7% and 1%, ... Not part of subscription

Leveraging advanced medical imaging and AI helps GE continue rolling out its cancer solutions

News Commentary | July 09, 2021

GE Healthcare is partnering with Sophia Genetics to further improve the quality of customized treatments that suit individual patients' genomic profile cancer types inorganically. Sophia's AI‑enabled analytics platform will help GE Healthcare leverage its medical imaging and monitoring and Edison ... Not part of subscription

Unlocking new business opportunities earlier in the patient journey by integrating genomics technologies with existing healthcare products and services

Analyst Insight | August 28, 2021

Historically, genomic sequencing has been widely used in research settings for population‑scale data‑driven insights. With the increase in the availability of genomic data, genomics can also now be leveraged to derive actionable health insights at the individual level, unlocking the promise of ... Not part of subscription